37 related articles for article (PubMed ID: 34665989)
1. High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Necchi A; Mariani L; Di Nicola M; Lo Vullo S; Nicolai N; Giannatempo P; Raggi D; Farè E; Magni M; Piva L; Matteucci P; Catanzaro M; Biasoni D; Torelli T; Stagni S; Bengala C; Barone C; Schiavetto I; Siena S; Carlo-Stella C; Pizzocaro G; Salvioni R; Gianni AM
Ann Oncol; 2015 Jan; 26(1):167-172. PubMed ID: 25344361
[TBL] [Abstract][Full Text] [Related]
2. Long-term toxicity of cisplatin in germ-cell tumor survivors.
Chovanec M; Abu Zaid M; Hanna N; El-Kouri N; Einhorn LH; Albany C
Ann Oncol; 2017 Nov; 28(11):2670-2679. PubMed ID: 29045502
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pediatric extracranial germ cell tumors: A single center experience in a developing country.
Saliyeva S; Boranbayeva R; Bulegenova M; Zhumadullayev B; Nurzhanova G; Manzhuova L
Rare Tumors; 2024; 16():20363613231216567. PubMed ID: 38566825
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer.
Meng X; Ahmed M; Courtney KD; Arafat W; Ibrahim I; Margulis V; Nichols C; Bagrodia A
Front Oncol; 2021; 11():724682. PubMed ID: 34692501
[TBL] [Abstract][Full Text] [Related]
5. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll HJ
Ann Oncol; 1996 Dec; 7(10):1015-21. PubMed ID: 9037359
[TBL] [Abstract][Full Text] [Related]
7. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Ramanathan S; Prasad M; Vora T; Badira CP; Kembhavi S; Ramadwar M; Khanna N; Laskar S; Muckaden MA; Qureshi S; Banavali S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Apr; 70(4):e30179. PubMed ID: 36645132
[TBL] [Abstract][Full Text] [Related]
10. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.
Frazier AL; Stoneham S; Rodriguez-Galindo C; Dang H; Xia C; Olson TA; Murray MJ; Amatruda JF; Shaikh F; Pashankar F; Billmire D; Krailo M; Stark D; Brougham MFH; Nicholson JC; Hale JP
Eur J Cancer; 2018 Jul; 98():30-37. PubMed ID: 29859339
[TBL] [Abstract][Full Text] [Related]
11. Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis.
Jain R; Menon P; Bansal D; Kakkar N; Radhika S; Rao KLN; Trehan A
Pediatr Hematol Oncol; 2022 Apr; 39(3):267-277. PubMed ID: 34665989
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.
Oing C; Seidel C; von Amsberg G; Oechsle K; Bokemeyer C
Expert Opin Pharmacother; 2016; 17(4):545-60. PubMed ID: 26630452
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
